AEON Biopharma (AEON)

• Market cap: $28.8M
• 1 day: 1.75%
• 5 days: 0.87%
• 1 month: 19.59%
• 3 months: 19.59%
• 6 months: 55.08%
• Year to date: 4.5%
• 1 year: 58.9%
• 5 years: -99.83%
• 10 years: -99.83%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5